Royal Bank Of Canada Intra Cellular Therapies, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 136,068 shares of ITCI stock, worth $17.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,068
Previous 40,634 234.86%
Holding current value
$17.3 Million
Previous $2.78 Million 257.49%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $6.49 Million - $7.71 Million
95,434 Added 234.86%
136,068 $9.95 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $169,930 - $209,500
2,624 Added 6.9%
40,634 $2.78 Million
Q1 2024

Nov 05, 2024
SELL
$64.37 - $75.65 $168,906 - $198,505
-2,624 Reduced 6.46%
38,010 $2.63 Million
Q1 2024

May 15, 2024
SELL
$64.37 - $75.65 $1.9 Million - $2.23 Million
-29,453 Reduced 43.66%
38,010 $2.63 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $860,951 - $1.37 Million
18,567 Added 37.97%
67,463 $4.83 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $850,108 - $1.05 Million
-16,320 Reduced 25.02%
48,896 $2.55 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $572,230 - $695,427
10,467 Added 19.12%
65,216 $4.13 Million
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $43,668 - $56,819
-997 Reduced 1.79%
54,749 $2.96 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $521,568 - $644,415
11,835 Added 26.95%
55,746 $2.95 Million
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $1.07 Million - $1.5 Million
24,967 Added 131.79%
43,911 $2.04 Million
Q2 2022

Aug 15, 2022
SELL
$43.0 - $65.64 $149,726 - $228,558
-3,482 Reduced 15.53%
18,944 $1.08 Million
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $542,205 - $869,011
-13,996 Reduced 38.43%
22,426 $1.37 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $234,819 - $356,364
6,671 Added 22.42%
36,422 $1.91 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $296,735 - $439,006
10,332 Added 53.21%
29,751 $1.11 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $568,976 - $864,145
19,419 New
19,419 $793,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email